Entries of Aldape, Ken on the publication server

van den Bent, Martin J., Baumert, Brigitta, Erridge, Sara C., Vogelbaum, Michael A., Nowak, Anna K. , Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M., Baurain, Jean Francais, Mason, Warren P., Wheeler, Helen, Chinot, Olivier L., Gill, Sanjeev, Griffin, Matthew, Brachman, David G., Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H., Weber, Damien C., Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Pascoe, Sarah, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, van Heuvel, Irene, Stupp, Roger, Aldape, Ken, Jenkins, Robert B., Dubbink, Hendrikus Jan, Dinjens, Winand N. M., Wesseling, Pieter , Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, Wick, Wolfgang and Kros, Johan M. (2017) Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. The Lancet 390 (10103), pp. 1645-1653. Fulltext not available.